Marc Foretz
Foretz, Marc
VIAF ID: 313574835 (Personal)
Permalink: http://viaf.org/viaf/313574835
Preferred Forms
-
100 1 _ ‡a Foretz, Marc
-
100 0 _ ‡a Marc Foretz
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Caractérisation des effets centraux de la metformine sur des modèles murins sains ou obèses et diabétiques |
![]() |
Central effects of metformin in healthy, or obese and diabetic mice models. |
![]() |
Effet de la metformine, un modulateur du métabolisme sur le développement gonadique : utilisation de deux modèles expérimentaux |
![]() |
Endospanin1 affects oppositely body weight regulation and glucose homeostasis by differentially regulating central leptin signaling |
![]() |
Enhanced Muscle Insulin Sensitivity After Contraction/Exercise Is Mediated by AMPK. |
![]() |
Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding. |
![]() |
Expression of Uncoupling Protein 3 and GLUT4 Gene in Skeletal Muscle of Preterm Newborns: Possible Control by AMP-Activated Protein Kinase |
![]() |
[From cancer to diabetes treatment : the tumor suppressor LKB1 as a new pharmacological target]. |
![]() |
A functional role for AMPK in female fertility and endometrial regeneration |
![]() |
Glucose availability but not changes in pancreatic hormones sensitizes hepatic AMPK activity during nutritional transition in rodents |
![]() |
Haptoglobin is degraded by iron in C57BL/6 mice: a possible link with endoplasmic reticulum stress |
![]() |
Hepatic glucose sensing is required to preserve β cell glucose competence |
![]() |
Hepatic peroxisome proliferator-activated receptor γ coactivator 1α and hepcidin are coregulated in fasted/refed states in mice. |
![]() |
Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype |
![]() |
Important role for AMPKalpha1 in limiting skeletal muscle cell hypertrophy |
![]() |
Inactivation of AMPKα1 induces asthenozoospermia and alters spermatozoa morphology |
![]() |
Increased FAT/CD36 cycling and lipid accumulation in myotubes derived from obese type 2 diabetic patients |
![]() |
The inhibitory effect of glucose on phosphoenolpyruvate carboxykinase gene expression in cultured hepatocytes is transcriptional and requires glucose metabolism |
![]() |
Intestinal Epithelial AMPK Deficiency Causes Delayed Colonic Epithelial Repair in DSS-Induced Colitis |
![]() |
Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice |
![]() |
Intramyocellular lipid accumulation is associated with permanent relocation ex vivo and in vitro of fatty acid translocase (FAT)/CD36 in obese patients |
![]() |
Investigation of salicylate hepatic responses in comparison with chemical analogues of the drug |
![]() |
Leishmania infantum modulates host macrophage mitochondrial metabolism by hijacking the SIRT1-AMPK axis |
![]() |
Lipoprotein internalisation induced by oncogenic AMPK activation is essential to maintain glioblastoma cell growth. |
![]() |
Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin |
![]() |
Liver AMP-Activated Protein Kinase Is Unnecessary for Gluconeogenesis but Protects Energy State during Nutrient Deprivation |
![]() |
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation |
![]() |
LKB1 and AMPK regulate synaptic remodeling in old age |
![]() |
LKB1 and AMPKα1 are required in pancreatic alpha cells for the normal regulation of glucagon secretion and responses to hypoglycemia |
![]() |
The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver |
![]() |
Loss of hepatic AMP-activated protein kinase impedes the rate of glycogenolysis but not gluconeogenic fluxes in exercising mice. |
![]() |
Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3 |
![]() |
Maintenance of red blood cell integrity by AMP-activated protein kinase alpha1 catalytic subunit. |
![]() |
Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. |
![]() |
Mechanism of action of compound-13: an α1-selective small molecule activator of AMPK |
![]() |
Mechanism of inhibition of hepatic glucose production by metformin: a new concept for an old remedy |
![]() |
Metabolic and Innate Immune Cues Merge into a Specific Inflammatory Response via the UPR |
![]() |
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status |
![]() |
Metformin: from mechanisms of action to therapies |
![]() |
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state |
![]() |
Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation |
![]() |
Mitochondrial fission and remodelling contributes to muscle atrophy. |
![]() |
Modifying the Dietary Carbohydrate-to-Protein Ratio Alters the Postprandial Macronutrient Oxidation Pattern in Liver of AMPK-Deficient Mice. |
![]() |
Motif affinity and mass spectrometry proteomic approach for the discovery of cellular AMPK targets: identification of mitochondrial fission factor as a new AMPK substrate |
![]() |
Myeloid deletion and therapeutic activation of AMPK do not alter atherosclerosis in male or female mice |
![]() |
Myeloid-Restricted AMPKα1 Promotes Host Immunity and Protects against IL-12/23p40-Dependent Lung Injury during Hookworm Infection. |
![]() |
Nervous glucose sensing regulates postnatal β cell proliferation and glucose homeostasis |
![]() |
No title available. |
![]() |
Obesity Impairs Skeletal Muscle Regeneration Through Inhibition of AMPK. |
![]() |
Overexpression of AMP-activated protein kinase or protein kinase D prevents lipid-induced insulin resistance in cardiomyocytes |
![]() |
Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain |
![]() |
Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation |
![]() |
Phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) is an AMPK target participating in contraction-stimulated glucose uptake in skeletal muscle |
![]() |
Polyunsaturated fatty acids inhibit fatty acid synthase and spot-14-protein gene expression in cultured rat hepatocytes by a peroxidative mechanism. |
![]() |
PPARγ contributes to PKM2 and HK2 expression in fatty liver |
![]() |
PRKAA1/AMPKα1 is required for autophagy-dependent mitochondrial clearance during erythrocyte maturation |
![]() |
The PRKAA1/AMPKα1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMML |
![]() |
Proglucagon Promoter Cre-Mediated AMPK Deletion in Mice Increases Circulating GLP-1 Levels and Oral Glucose Tolerance. |
![]() |
Régulation du métabolisme énergétique par l’AMPK |
![]() ![]() |
Regulation of hepatic lipid metabolism by AMPK : implications in the development and the treatment of fatty liver. |
![]() |
ROLE DU FACTEUR DE TRANSCRIPTION SREBP-1C DANS L'ACTIVATION TRANSCRIPTIONNELLE DES GENES DE LA GLYCOLYSE ET DE LA LIPOGENESE PAR L'ENVIRONNEMENT GLUCIDIQUE DANS LE FOIE |
![]() |
S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. |
![]() |
Salt-inducible kinases dictate parathyroid hormone 1 receptor action in bone development and remodeling |
![]() |
Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential: (Trends Endocrinol. Metab. 29, 723-735, 2018) |
![]() |
[« Self-eating » to survive - coordinated regulation of autophagy by nutrients]. |
![]() |
Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver |
![]() |
SIK2 regulates CRTCs, HDAC4 and glucose uptake in adipocytes |
![]() |
SIKs control osteocyte responses to parathyroid hormone |
![]() |
A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators. |
![]() |
Specific deletion of AMP-activated protein kinase (α1AMPK) in murine oocytes alters junctional protein expression and mitochondrial physiology |
![]() |
Sterol regulatory element-binding protein-1c mimics the negative effect of insulin on phosphoenolpyruvate carboxykinase |
![]() |
Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver |
![]() |
The stress polarity signaling (SPS) pathway serves as a marker and a target in the leaky gut barrier: implications in aging and cancer |
![]() |
Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. |
![]() |
Therapy: Metformin takes a new route to clinical efficacy |
![]() |
TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance |
![]() |
Transcriptional block of AMPK-induced autophagy promotes glutamate excitotoxicity in nutrient-deprived SH-SY5Y neuroblastoma cells |
![]() |
Transgenic Mice Expressing Human Proteinase 3 Exhibit Sustained Neutrophil-Associated Peritonitis. |
![]() |
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus |
![]() |
α1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation |
![]() |
α1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunction |
![]() |